Annual report pursuant to Section 13 and 15(d)

Financial instruments - Collaboration and License Agreement (Details)

v3.8.0.1
Financial instruments - Collaboration and License Agreement (Details)
$ in Thousands
6 Months Ended 12 Months Ended 43 Months Ended
Dec. 31, 2015
customer
Dec. 31, 2017
USD ($)
customer
Dec. 31, 2016
USD ($)
customer
Jun. 30, 2015
customer
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Collaboration and License Agreement            
Number of customers | customer 1 1 1 1    
GlaxoSmithKline Intellectual Property Development Ltd | Collaboration and License Agreement            
Collaboration and License Agreement            
Trade receivables     $ 1,500     $ 200
Impairment losses         $ 0  
Amounts past due   $ 0     $ 0